Bluejay Diagnostics Inc (BJDX) SEC 13F Holdings (Q2 2026): Institutional Buyers & Sellers

BJDX ranks #10594 out of 37701 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

8 institutions disclose a position in BJDX, but none treat it as a major bet — even Heights Capital Management, Inc, its most concentrated holder, allocates just 0.0% of its own portfolio to it.

BJDX reported a net loss of $6.8M in its latest fiscal year.

• Not yet profitable — net loss of $6.8M in the latest fiscal year
• Net income improved year over year, from -$7.7M to -$6.8M
• Operating cash flow was negative, using $6.1M in cash
• Current ratio of 4.88x — enough short-term assets to cover short-term liabilities
• Liabilities run 0.19x equity — within a conventional range